Introduction: The process of hematopoietic stem cell transplantation has developed and is one of the most unique procedures in medicine today. Rejection of the graft against the host, however, remains a major obstacle to its success. It is described as a reaction of donor immune cells against host tissues. Nursing of patients with graft rejection against the host after hematopoietic stem cell transplantation, due to its specificity, requires an additional set of knowledge and skills of nurses. Purpose: The purpose of this thesis is to present the complexity and specifics of nursing patients in the formation of a graft against the host after transplantation of hematopoietic stem cells. Methods of work: The diploma thesis uses a descriptive method of work with a review of foreign literature, searched in databases MedLine, Sience Direct, Taylor & Francis, Crossref, CINAHL and Web of science using the search engines Pubmed and EBSCOhost and the web browser Google Scholar. Data were accessed remotely through the library of the Faculty of Medicine. The literature search took place in the period from February to November 2021. 27 foreign articles and 1 Slovenian article were included in the analysis. Results: We found that the incidence of graft rejection versus host was increasing due to progress treatment with hematopoietic stem cell transplantation. Graft rejection versus host it is the most common late complication and significantly affects the long-term quality of a patient’s life. Specialized clinics are being set up around the world to care for such patients, and nurses are specializing in the complexity and specificity of nursing. CAR-T cell therapy has been shown to be an effective drug in combating graft rejection against the host. Discussion and Conclusion: Acute and chronic graft rejection versus host are complications that continue to limit the lives of patients after hematopoietic stem cell transplantation. The nursing of such a patient requires unique knowledge and skills. However, with the current development of treatment and the findings of hematopoietic stem cell transplantation, CAR-T cell therapy would eliminate the potential for graft rejection against the host in allogeneic transplants.
|